Drug discovery > Pre-Clinical Development Products & Reviews

The Infliximab ELISA kit is intended for the quantitative determination of Infliximab in serum, plasma and cell culture samples. Validated against NIBSC international standards from WHO.

Enzyme Immunoassay for the quantitative determination of Anti-Natalizumab antibodies in serum and plasma.

Enzyme Immunoassay for the quantitative determination of Sacituzumab Govitecan in human serum and plasma.

Immunoassay for the measurement of Bovine Serum Albumin in cell culture samples.

Immunoassay for the measurement of Protein A in samples containing Human immunoglobulin.

The Desmpressin ELISA kit is intended for the quantitative determination of Desmopressin in serum and plasma samples.

Enzyme Immunoassay for the quantitative determination of Anti-Adalimumab antibodies in human serum and plasma.

Enzyme Immunoassay for the Qualitative / Quantitative Screening of double stranded RNA in mRNA based preparations.

Immunoassay for the measurement of E.coli Host Cell Proteins

ELISA for the detection of Blinatumomab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year